BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Topics
»
Disease categories and therapies
» Urology
Urology
RSS
Action starts phase II trial with AP-214 for organ failure associated with surgery
July 1, 2008
FDA Advisory Committee recommends approval of tolvaptan
June 26, 2008
Nymox presents new data for NX-1207 in benign prostatic hyperplasia
June 26, 2008
FDA approves Avodart in combination with tamsulosin for enlarged prostate
June 23, 2008
Nymox commences phase III NX-1207 program
June 11, 2008
Recent Roche patent reports new therapeutic agents for urological disorders
June 9, 2008
Nabi receives a USD 2.5 million milestone payment from Fresenius for CARE-2 study
June 6, 2008
Altus reports top-line results from ALTU-237 phase I clinical trial
June 4, 2008
Nymox reports significant improvement in BPH symptoms after NX-1207 treatment
May 30, 2008
EMEA notified by sanofi-aventis of its withdrawal of the MAA for Aquilda
May 30, 2008
Previous
1
2
…
138
139
140
141
142
143
144
145
146
…
318
319
Next
RSS